V

Vetigenics

4 employees

Vetigenics discovers and develops antibody-based immunotherapies to treat cancer and chronic diseases in companion animals

Basic info

Industry

biotechnology research

Sectors

Biotechnology
CAR-T
Immunotherapy
Antibodies
Veterinary Medicine
Animal Health
Pet
Cellular Therapy

Date founded

2017

Funding rounds raised

V

Vetigenics raised undisclosed on February 1, 2021

Investors: Newchip

FAQ